Emtricitabine/Tenofovir Alafenamide (Descovy) for HIV
Emtricitabine/Tenofovir Alafenamide (Descovy) for HIV
August 1, 2016 (Issue: 1500)
The FDA has approved Descovy (Gilead), a fixed-dose
combination of the nucleoside/nucleotide reverse
transcriptase inhibitors (NRTIs) emtricitabine (FTC)
and tenofovir alafenamide (TAF) for use with other
antiretroviral agents for treatment of...more
- Genvoya – a new 4-drug combination for HIV. Med Lett Drugs Ther 2016; 58:19.
- Odefsey – another NNRTI combination for HIV. Med Lett Drugs Ther 2016; 58:60.
- Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available at: aidsinfo.nih.gov. Accessed July 21, 2016.
- A Pozniak et. Switching to tenofovir alafenamide, coformulated with elvitegravir, cobicistat, and emtricitabine, in HIV-infected patients with renal impairment: 48-week results from a single-arm, multicenter, open-label phase 3 study. J Acquir Immune Defic Syndr 2016; 71:530.
- D Wohl et al. A randomized, double-blind comparison of tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for HIV-1 treatment: 96-week results. J Acquir Immune Defic Syndr 2016; 72:58.
- HF Günthard et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults. 2016 recommendations of the International Antiviral Society - USA Panel. JAMA 2016; 316:191.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to
The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App
- FREE online per issue CME/CE
Purchase this article:
Title: Emtricitabine/Tenofovir Alafenamide (Descovy) for HIV
Article code: 1500c
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
